Composite Interceptive Med Sciences Laboratories

Composite Interceptive Med Science (CIMS) is a specialized pharmaceutical division of Wockhardt Limited, a global biotechnology and pharmaceutical company headquartered in Mumbai, India. The division focuses on the marketing and distribution of branded generic medications, primarily targeting chronic therapeutic segments such as cardiology, diabetology, nephrology, and neuropsychiatry. CIMS offers a robust portfolio of products, including well-known brands for the management of hypertension, diabetes, and neuropathic pain, serving a significant portion of the Indian healthcare market. By leveraging Wockhardt's extensive research and development and manufacturing infrastructure, CIMS ensures the delivery of high-quality, affordable therapeutic solutions. The division is recognized for its strong field force and deep engagement with medical professionals across India.